Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction

Annals of Hepatology

Volumn 5, Issue 1, 2006, Pages 34-40

  Torres Baranda, Rodrigo ^a   Bastidas Ramírez, Blanca E ^d   Maldonado González, Montserrat ^a   Sánchez Orozco, Laura V ^a   Vázquez Vals, Eduardo ^c   Rodríguez Noriega, Eduardo ^b   Panduro, Arturo ^a  

^a Department of Molecular Biology in Medicine ^*  (Mexico)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Co infection HBV HIV; HBV DNA; Immunosilent HBV infection; Lack of HBsAg detection; Serologic markers

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AIDS PATIENT; ARTICLE; BIOCHEMISTRY; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GENOTYPE; HEPATITIS; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIVER INJURY; MALE; MEDICAL PARAMETERS; MEXICO; MORBIDITY; OCCULT HEPATITIS B; POLYMERASE CHAIN REACTION; REINFECTION; RELIABILITY; RISK FACTOR; SERODIAGNOSIS; VIRUS TRANSMISSION;

EID: 33645755000     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)32037-x     Document Type: Article

References (44)

1. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-1340.
2. Ganem D, Prince AM. Hepatitis B virus infection, natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
3. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-366.
4. Coursaget P, LeCann P, Leboulleux D, Diop MT, Bao O, Coll AM. Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalense patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett 1991; 67: 35-39.
5. Rustgi V, Hoofnagle JH, Guerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM. Hepatitis B infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101(6): 795-797.
6. Chamorro AJ, Casado JL, Bellido D, Moreno S. Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis 2005; 24: 492-494.
7. Koff RS. Hepatitis B and Hepatitis D, In S. L. Gorbach, J. G. Bartlett, N. R. Blacklow, eds. Infectious Dissease, 3rd ed. Philadelphia, PA. Lippncott Williams and Wilkins, Inc., 2004; 765-784.
8. Hoofnagle H, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991; 11: 73-83.
9. De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J, Van Thiel DH. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000; 95(12): 3529-36.
10. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58(3): 201-7.
11. Torbenson M, Thomas DL. Occult hepatitis B Lancet Infect Dis 2002; 2: 479-486.
12. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace. Hepatology 2001; 34: 204-205.
13. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R. The prevalence of surface antigen variants of Hepatitis B virus in Papua New Guinea, South Africa and Sardinia. Hepatology 1997; 26: 1658-1666.
14. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 2001; 34: 194-203.
15. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120: 1009-1022.
16. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188.
17. Vandercam B, Cornu C, Gala JL, Geubel A, Cahill M, Lamy ME. Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 1990; 9(9): 701-702.
18. a Asamblea general de Edimburgo, Escocia, octubre de 2000.
19. st ed. Washington, DC: American Society for Microbiology. 1993; 32-325.
20. Sánchez LV, Maldonado M, Bastidas-Ramírez BE, Norder H, Panduro A. Genotypes and S-Gene variability of Mexican Hepatitis B virus Strains. J Med Virol 2002; 68: 24-32.
21. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2: 1273-1276.
22. Liang T, Hasegawa K, Rimon N, Wands J, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. New Engl J Med 1991; 4: 1705-1709.
23. Salmon-Ceron D, Lewden C, Morlar P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatology 2005; 42: 799-805.
24. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. New Engl J Med 1990; 323: 80-85.
25. Cabrerizo M, Bartolome J, De Sequera P, Caramelo C, Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol 1977; 8: 1443-1447.
26. Nuñez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002; 18(15): 2099-2101.
27. Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC, Li JS, et al. Transmission of serologically silent hepatitis-b virus along with hepatitis-c virus in two cases of posttransfusion hepatitis. Transfusion 1992; 32: 215-220.
28. Hui Ch, Sun J, Au W, Lie AKW, Yueng Y, Zhang H, Lee NP, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatology 2005; 42: 813-819.
29. Shire NJ, Rouster SD, Rajicic NBS, Sherman KE. Occult Hepatitis B in HIV-Infected Patients. J Acquir Immune Defc Syndr 2004; 36(3): 860-875.
30. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 1991; 163: 1138-1140.
31. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11(5): 597-606.
32. Homann C, Krogsgaard K, Petersen C, Andersson P, Nielsen JQ. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J Acquir Immune Defy Syndr 1991; 4: 416-420.
33. Kingsley LA, Rinaldo CR Jr, Lyter DW, Valdiserri RO, Belle SH, Ho M. Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA 1990; 264(2): 230-4.
34. Laure F, Zagury D, Saimot AG, Gallo RO, Hahn BH, Brechor C. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science 1985; 229: 561-63.
35. Thimme R, Spangenberg HC, Blum HE. Hepatitis B or hepatitis C and human immunodeficiency virus infection. J Hepatology 2005; 42: S37-S44.
36. Hawkins AE, Gilson RJ, Gilbert N, Wreghitt TG, Gray JJ, Ahlers-de Boer I, Tedder RS, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996; 24(1): 8-14.
37. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-1174.
38. Lebovics E, Dworkinn B, Heier S, Rosenthal W. The hepatobilliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol 1988; 83: 1-7.
39. Thio CL. Hepatitis B in the human immunodeficiency virus-infected patient: Epidemiology, Natural History, and treatment. Seminars Liv Dis 2003; 23(2): 125-136.
40. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17: 6-13.
41. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palù G, et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatology 2005; 42: 615-624.
42. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepatitis 2002; 9: 243-257.
43. Raimondo G, Cacciamo C, Saitta C. Hepatitis B virus and hepatitis C virus co-infection additive players in chronic liver disease? Annals of Hepatology 2005; 4(2): 100-106.
44. García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, México. Transfus Med 2005; 15(5): 371-378.